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USP21 deubiquitylates Nanog to regulate protein stability and
stem cell pluripotency
Xingyu Liu1,2,9, Yuying Yao3,9, Huiguo Ding1,9, Chuanchun Han3, Yuhan Chen2, Yuan Zhang2, Chanjuan Wang2, Xin Zhang4,
Yiling Zhang5, Yun Zhai1, Ping Wang6, Wenyi Wei7, Jing Zhang8 and Lingqiang Zhang2,3
The homeobox transcription factor Nanog has a vital role in maintaining pluripotency and self-renewal of embryonic stem cells
(ESCs). Stabilization of Nanog proteins is essential for ESCs. The ubiquitin–proteasome pathway mediated by E3 ubiquitin ligases
and deubiquitylases is one of the key ways to regulate protein levels and functions. Although ubiquitylation of Nanog catalyzed by
the ligase FBXW8 has been demonstrated, the deubiquitylase that maintains the protein levels of Nanog in ESCs yet to be deﬁned.
In this study, we identify the ubiquitin-speciﬁc peptidase 21 (USP21) as a deubiquitylase for Nanog, but not for Oct4 or Sox2. USP21
interacts with Nanog protein in ESCs in vivo and in vitro. The C-terminal USP domain of USP21 and the C-domain of Nanog are
responsible for this interaction. USP21 deubiquitylates the K48-type linkage of the ubiquitin chain of Nanog, stabilizing Nanog.
USP21-mediated Nanog stabilization is enhanced in mouse ESCs and this stabilization is required to maintain the pluripotential
state of the ESCs. Depletion of USP21 in mouse ESCs leads to Nanog degradation and ESC differentiation. Overall, our results
demonstrate that USP21 maintains the stemness of mouse ESCs through deubiquitylating and stabilizing Nanog.
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INTRODUCTION
Embryonic stem cells (ESCs) and induced pluripotent stem cells
are pluripotent stem cell lines that have the ability to self-renew
and differentiate into multiple lineages.1 The pluripotency of ESCs
is controlled by a series of core transcription factors, such as
Nanog, Oct4 and Sox2.2–4 Knowing the transcription factors that
regulate the pluripotency of ESCs, human-induced pluripotent
stem cells can be produced by the combined expression of these
factors (that is, Oct4, Sox2, Nanog and LIN28 or Oct4, Sox2, c-Myc
and KLF4).5–7 Nanog, ﬁrst discovered in 2003 as a critical factor
that underlies pluripotency in both the inner cell mass and ESCs, is
capable of maintaining ESC self-renewal independent of leukemia
inhibitory factor (LIF)/Stat34,8 and is expressed in pluripotent
embryonic cells, derivative ESCs and the developing germ line of
mammals and birds. Nanog-deﬁcient inner cell mass failed to
generate epiblast and only produced parietal endoderm-like cells.
Nanog-deﬁcient ESCs lost pluripotency and differentiated into
extraembryonic endoderm lineage.4,8 Overexpression of Nanog
allows mouse (m)ESCs to remain pluripotent even without LIF and
enables human ESCs to grow feeder-free and form clones
efﬁciently.8,9 In contrast, reduced expression of Nanog in ESCs
leads to differentiation.4,10 So, it is not surprising that the tight
regulation of Nanog expression levels is of great importance.
Previous studies have demonstrated that transcription factors
are needed to activate and/or suppress Nanog expression. In this
regard, Oct4 and Sox2 have been shown to be the main regulators
of Nanog expression in mESCs.11–13 Oct4, Sox2 and Nanog often
co-occupy a substantial portion of their target genes and
collaborate to form regulatory circuitry consisting of autoregula-
tory and feed-forward loops. In addition, epigenetic factors,
including Wdr5, Mof and Ezh2, can modulate Nanog transcription
in ESCs.14–16
Recent studies showed that post-translational modiﬁcations
(PTMs) also have important and complex roles in the control of
pluripotency and cellular reprogramming. Ubiquitylation is one
of the most important PTMs to control protein stability. The
ubiquitin–proteasome system mediates the rapid and highly
speciﬁc addition or removal of ubiquitin to intracellular proteins
and thereby contributes to the dynamic regulation of protein
abundance, including stem cell transcription factors. The E3
ubiquitin ligase, F-box and WD40 domain-containing protein 8
(FBXW8), has been recently reported to promote Nanog poly-
ubiquitylation and degradation, and result in ESC differentiation.17
Interestingly, FBXW8 binding to Nanog requires the phosphoryla-
tion of Nanog at N-terminal Serines 52, 71 and 78 by the kinase
ERK1. Consistent with this notion, a recent systemic ‘ubiproteome’
study in ESCs and induced pluripotent stem cells has found that
the ubiquitin–proteasome system constitutes a major level of
regulation of the pluripotency and reprogramming of these
cells.18 More than 1000 proteins were identiﬁed to be ubiquity-
lated in mESCs in the pluripotent or differentiated states. Many
well-characterized members of the extended pluripotency
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network, such as Nanog and Oct4, are themselves ubiquitylated in
the pluripotent cells.18
Deubiquitylases (DUBs, also called deubiquitinases) can
remove ubiquitin molecules from protein substrates and maintain
their stability. There are ~ 90 DUBs in the human proteome
including ubiquitin C-terminal hydrolyases (UCHs), ubiquitin-
speciﬁc peptidases (USPs), ovarian tumor domain enzymes (OTUs),
Josephins, Jad/Pad/MPN domain-containing metallo enzymes and
monocyte chemotactic protein-induced proteins.19–21 So far, the
DUB that regulates Nanog protein stability remains unknown.
In this study, we identiﬁed USP21 as an efﬁcient DUB that
reverses Nanog polyubiquitylation and stabilizes Nanog protein.
Our study further demonstrates that depletion of USP21 in mESCs
leads to Nanog degradation and mESC differentiation. These
results provide a potential resource for cell substitutive therapy
and drug discovery.
MATERIALS AND METHODS
Cell culture
Mouse ESC lines R1 and E14 were maintained in dishes without feeder cells
but with 0.3% gelatin and α-minimum essential medium (Hyclone, Logan,
UT, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone), 1%
penicillin–streptomycin solution, 2 mM L-glutamine (Invitrogen, Carlsbad,
CA, USA), 100 μM non-essential amino acids (Invitrogen), 0.1 mM sodium
pyruvate (Invitrogen), 0.1 mM β-mercaptoethanol (Sigma, St Louis, MO,
USA) and 1000 U ml− 1 LIF (Millipore, Temecula, CA, USA) at 37 °C and 5%
CO2. For LIF withdrawal differentiation assays, mESCs were cultured in
medium containing the supplements listed above at the concentrations
indicated but without LIF. Human embryonic carcinoma NCCIT cells and
human embryonic kidney HEK293T cells were cultured with Dulbcco's
modiﬁed Eagle's medium supplemented with 10% fetal bovine serum.
Plasmids and antibodies
Human DUB library was purchased from OriGene (Rockville, MD, USA).
USP21 and Nanog full-length and mutants were sub-cloned into pCMV-
Myc or pFlag-CMV-2 vectors as indicated. GST-tagged USP21 and Nanog
were inserted into the pGEX-6P-1 or pET-28a vector. Cells were transfected
with various plasmids using TuboFect reagent (Thermo, Waltham, MA,
USA) according to the manufacturer’s protocol. The antibodies we used in
this study are as follows: anti-Flag (MBL, Woburn, MA, USA), anti-Myc (MBL),
anti-Nanog (Bethyl, Montgomery, UK; CST), anti-USP21 (Santa Cruz Inc.,
Santa Cruz, CA, USA), anti-Oct4 (Santa Cruz Inc.), anti-His (Santa Cruz Inc.),
anti-GST (Santa Cruz Inc.), anti-HA (MBL), anti-actin (Santa Cruz Inc.), anti-
mouse secondary antibody (Sigma), anti-rabbit secondary antibody
(Sigma) and anti-goat secondary antibody (Abbkine, Redlands, CA, USA).
Lentiviral packaging for knockdown experiment
USP21 was knocked down in ESCs and NCCIT cells using a lentiviral system.
Short hairpin RNAs (shRNAs) were constructed by inserting shRNA
sequences into a pGIPZ vector. The sense sequences of shRNA were as
following: #1: 5′-TGCTAGAAGAACCTGAGTT-3′, #2: 5′-CAGTTGAAAAGTTGT
CTCA-3′, #3: 5′-TCACTAAGGAAGAAGAGCT-3′ and #4: 5′-AACCTAATGTG
GAAACGTT-3′. Infective lentiviruses were produced by co-transfection of
the expression vector and packaging plasmids into 293FT cells, which were
added to NCCIT cells and ESCs.
Co-immunoprecipitation assay
Cells were lysed in HEPES buffer (20 mM HEPES, 50 mM NaCl, 0.5% Triton-X
100, 1 mM NaF) supplemented with protease inhibitor cocktail and
dithiothreitol. The cell lysates were used for co-immunoprecipitation
assays. Cell lysates were immunoprecipitated with the indicated antibodies
for 3 h at 4 °C and then incubated with protein A/G (Santa Cruz Inc.) for
overnight at 4 °C. Protien A/G-agarose was washed with HEPES buffer three
times and then analyzed by western blot with the indicated antibodies.
GST pull-down assay
Escherichia coli BL21-expressing GST or GST-USP21 proteins were
immobilized on glutathione-Sepharose 4B beads then washed. These
beads were next incubated with His-Nanog that was expressed in BL21
and puriﬁed by Ni-sepharose-agarose beads for 8–12 h at 4 °C. Then, the
beads were washed with elution buffer and then proteins were eluted for
western blotting.
In vivo ubiquitylation assay
For Nanog ubiquitylation analysis, HEK293T cells were transfected with HA-
ubiquitin, Myc-USP21, Myc-USP21CA or Flag-Nanog as indicated. Cells
were treated with the proteasome inhibitor MG132 (20 μM; Sigma) for
8–10 h. At 36 h after transfection, cells were lysed in RIPA buffer (50 mM
Tris-HCl, 1% NP-40, 1% sodium deoxycholate, 10% glycerinum, 150 mM
NaCl, 5 mM EDTA, 0.1% SDS) and then incubated with anti-Flag antibody
for 3 h and protein A/G-agarose beads overnight at 4 °C. After washing
three times, ubiquitylated Nanog was detected by immunoblotting using
anti-HA monoclonal antibody.
In vitro deubiquitylation assay
Flag-Nanog and HA-ubiquitin were co-expressed in HEK293T cells. After
treatment with the proteasome inhibitor MG132 (10 μM) for 8 h, the
ubiquitylated proteins were puriﬁed by immunoprecipitation with anti-
Flag antibodies. GST-USP21 protein puriﬁed from E. coli and the
ubiquitylated Nanog was incubated in elution buffer for 30 min at 25 °C.
The samples were then resolved by SDS-polyacrylamide gel electrophor-
esis followed by immunoblot analysis using anti-HA antibody.
RNA extraction and real-time RT-PCR
Total cell RNA was prepared using Trizol reagent (Sigma) following the
manufacturer’s instructions. First strand complementary DNA was synthe-
sized using ReverTra Ace qPCR RT Master Mix kit (TOYABO, Osaka, Japan)
following the manufacturer’s instructions. Real-time quantitative PCR was
performed using a KAPA SYBR FAST qPCR kit (Kapa Biosystems,
Wilmington, MA, USA). The sequences of real-time PCR primers are
below. GAPDH-RT-forward (F): 5′-TGTGTCCGTCGTGGATCTGA-3′, GAPDH-
RT-Reverse (R): 5′-CACCACCTTCTTGATGTCATCATAC-3′; Nanog-RT-F: 5′-CTC
ATCAATGCCTGCAGTTTTTCA-3′, Nanog-RT-R: 5′-CTCCTCAGGGCCCTTGTC
AGC-3′; Rex1-RT-F: 5′-ACGAGGTGAGTTTTCCGAAC-3′, Rex1-RT- R: 5′-CCTC
TGTCTTCTCTTGCTTC-3′; Oct4-RT-F: 5′-TCTTTCCACCAGGCCCCCGGCTC-3′,
Oct4-RT-R: 5′-TGCGGGCGGACATGGGGAGATCC-3′; Sox2-RT-F: 5′-TAGAG
CTAGACTCCGGGCGATGA-3′, Sox2-RT-R: 5′-TTGCCTTAAACAAGACCACG
AAA-3′; Gata4-RT-T: 5′-TGGAAGACACCCCAATCTCG-3′, Gata4-RT-R: 5′-TAG
TGTCCCGTCCCATCTCG-3′; Nestin-RT-F: 5′-CT GCAGGCCACTGAAAAGTT-3′,
Nestin-RT-R: 5′-GACCCTGCTTCTCCTGCTC-3′; USP21-RT-F: 5′-GCAGGATGC
CCAAGAGTT-3′, USP21-RT-R: 5′-GCAGGGACAGGTCACA AAA-3′.
Cytoplasmic and nuclear fractionation
R1 cells were collected and washed with ice-cold phosphate-buffered
saline twice. Cells were lysed in 250 μl lysis buffer (10 mM HEPES-NaOH (pH
7.9), 10 mM KCl, 1.5 mM MgCl2, 0.5 mM β-mercaptoethanol) supplemented
with protease inhibitor mixture and phosphatase inhibitor for 15 min then
lysis buffer plus 10% NP-40 was added for another 2 min. The lysate was
then centrifuged at 16 000 g for 10–15 min. After collecting the super-
natant containing the cytoplasmic fraction, the pellet was further lysed in
nuclear lysis buffer (10 mM Tris-HCl (pH 7.6), 420 mM NaCl, 0.5% Nonidet
P-40, 2 mM MgCl2, 1 mM dithiothreitol, 1 mM PMSF and 1% protease
inhibitor cocktail) for 20 min. After centrifugation, the supernatant,
constituting the nuclear fraction, was collected for further analysis.
Protein half-life assay
For Nanog protein half-life assays, cellular transfection was performed when
cells cultured in 2 cm plates reached ~60% conﬂuence. Twenty-four hours
later, cells were treated with the protein synthesis inhibitor cycloheximide
(Sigma, 10 μg ml−1) for the indicated durations before harvest.
Alkaline phosphatase staining
Alkaline phosphatase staining was carried out using the Leukocyte Alkaline
Phosphatase kit (Sigma). Cells were washed twice with phosphate-buffered
saline and ﬁxed with ﬁxative solution for 30 s at room temperature. The
cells were rinsed gently in deionized water twice and added to a alkaline-
dye mixture and then incubated at room temperature for 30 min followed
by being washed with deionized water. Alkaline phosphatase-positive
colonies were observed under a light microscope (Olympus, Tokyo, Japan).
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Statistics analysis
Statistical comparisons between two groups were carried out by Student’s
t-test and one-way analysis of variance. A two-tailed P-value o0.05 was
considered signiﬁcant.
RESULTS
DUB USP21 stabilizes Nanog protein
To identify the potential DUB for Nanog, a screen examining a
total of 32 DUBs, including USP and OTU subfamilies, was
performed. Given that endogenous Nanog is lowly expressed in
the human embryonic kidney cell line HEK293T, we overexpressed
the ectopic DUB and Nanog in the cells and analysed the
expression of Nanog. Through the screen, we found that USP21
signiﬁcantly upregulated Nanog levels, whereas other DUBs had
little to no effect on the Nanog expression levels (Figures 1a–c).
Overexpression of USP21, but not the catalytically inactive mutant
C221A, led to increased Nanog levels in a dose-dependent way
(Figure 2a), suggesting that USP21 upregulation of Nanog
expression is dependent on DUB enzyme activity. The effect of
USP21 on Nanog is speciﬁc since overexpression of USP21 seemed
to have little effect on Sox2 and Oct4 (Figure 2b), two well-
characterized transcription factors in stem cells. It has been
demonstrated that Nanog is abnormally overexpressed in human
embryonic carcinoma NCCIT cells, which demonstrate similar gene
expression proﬁles as ESCs.22 We then knocked down the
endogenous USP21 in NCCIT cells and examined the effects on
endogenous Nanog. Depletion of endogenous USP21 expression
with a shRNA appreciably downregulated Nanog protein in the
NCCIT cells and similar effects were observed with four individual
shRNAs (Figure 2c). However, the messenger RNA levels of Nanog
in NCCIT cells were not remarkably affected by depletion of USP21
(Figure 2d). These results suggest that USP21 has a role in the
maintenance of Nanog abundance.
To further conﬁrm that USP21 regulates the stability of Nanog,
we examined endogenous Nanog protein levels in the NCCIT cells
treated with cycloheximide, a protein synthesis inhibitor. The half-
life of endogenous Nanog protein in NCCIT cells is ~ 1 h.
Overexpression of USP21 prolonged the protein half-life of Nanog
to ~ 2 h, whereas the catalytically inactive mutant USP21 C221A
had no such effects (Figure 2e). Conversely, depletion of
endogenous USP21 with shRNA shortened the protein half-life
of Nanog (Figure 2f). These results indicate that USP21 speciﬁcally
stabilizes Nanog protein, with its effect is dependent on the DUB
activity of USP21.
USP21 interacts with Nanog in vivo and in vitro
To investigate whether USP21 interacts with Nanog, co-
immunoprecipitation assays were performed. We found that
ectopic Nanog and USP21 were reciprocally co-immunoprecitated,
and that their interaction was independent of the DUB activity of
USP21 (Figure 3a). Importantly, endogenous Nanog physiologi-
cally interacted with endogenous USP21 in mESCs (E14) and
human embryonic carcinoma NCCIT cells (Figure 3b). To
investigate whether the interaction between Nanog and USP21
was direct, we then performed GST pull-down assays. The results
showed that puriﬁed GST-USP21 but not GST alone could bind to
His-Nanog in vitro (Figure 3c), indicating a direct interaction
between Nanog and USP21. To evaluate the subcellular localiza-
tion of Nanog and USP21, nuclear/cytoplasmic fractionation was
performed. Once the cytoplasmic and nuclear fractions of the
mouse ESC R1 cells were separated, we found that Nanog and
USP21 were both predominantly detected in the nucleus of stem
cells (Figure 3d).
To map the binding region mediating the interaction between
Nanog and USP21, a series of deletion mutants were constructed
(Figure 4a). Co-immunoprecipitation assays showed that the
C-terminal USP domain of USP21 mediated its interaction with
Nanog (Figure 4b). The C-domain of Nanog, but not the N domain
nor the H (homeobox) domain of Nanog, was required for its
interaction with USP21 (Figure 4c). Taken together, the results
indicate that USP21 can interact with Nanog both in vivo and
in vitro.
USP21 deubiquitylates Nanog
As USP21 is a DUB, we hypothesized that USP21 stabilizes
Nanog through deubiquitylating Nanog. Indeed, we showed that
USP21 reduced Nanog ubiquitylation directly in an in vitro
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Figure 2. The deubiquitylase USP21 stabilizes Nanog protein in stem cells. (a) Flag-Nanog was co-transfected with increasing amounts of
USP21 WT or C221A mutant into HEK293T cells. Forty-eight hours later, Nanog expression was detected. (b) Nanog, Sox2 or Oct4 were each
co-transfected with increasing amounts of USP21 construct DNA into HEK293T cells. Forty-eight hours later, Nanog, Sox2 or Oct4 expression
were detected. (c) Nanog was analysed in NCCIT cells transfected with individual USP21 shRNA. (d) Depletion of USP21 had no statistically
signiﬁcant effect on Nanog messenger RNA (mRNA) level in NCCIT cells. n= 3 independent experiments. (e) NCCIT cells transfected with the
control vector, Myc-USP21 WT or Myc-USP21-C221A were treated with cycloheximide (CHX, 10 μg ml− 1) for the indicated time intervals, and
protein levels of endogenous Nanog and ectopic USP21 were detected by western blotting. Quantiﬁcation of Nanog levels relative to GAPDH
is shown on the right. Data are the representative results of three independent experiments. **Po0.01, ***Po0.001, Student’s
t-test. (f) NCCIT cells transfected with the control shRNA or USP21 shRNA were treated with CHX for the indicated times, and protein levels of
Nanog, USP21 were detected by western blotting. Quantiﬁcation of Nanog levels relative to GAPDH is shown on the right. **Po0.01 Student’s
t-test.
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deubiquitylation assay (Figure 5a). Ectopic expression of wild-type
USP21, but not the C221A mutant of USP21, removed the
ubiquitin chain of Nanog in cultured cells (Figure 5b). Consistent
with this notion, downregulation of USP21 by two individual
shRNAs increased Nanog ubiquitylation in NCCIT cells (Figure 5c).
Notably, USP21 efﬁciently removed K48-linked polyubiquitylation
of Nanog, but had no signiﬁcant effect on monoubiquitylation or
the nondegradative K63-linked polyubiquitylation of Nanog
(Figure 5d). Collectively, these data suggest that USP21 can
deubiquitylate and stabilize Nanog.
Knockdown of USP21 induces mouse ESC differentiation
Nanog is essential to maintain the stemness of ESCs. Considering
that USP21 deubiquitylates Nanog, we sought to examine the
functional roles of USP21 in mESCs. First of all, we examined the
protein levels of USP21 and Nanog in mouse embryonic ﬁbroblast
cells and mESCs E14 and R1. The protein expression of USP21 and
Nanog in mouse embryonic ﬁbroblast was much lower than that
in E14 and R1 cells (Figure 6a), suggesting that USP21 is highly
expressed in undifferentiated cells. After removal of LIF, the mESCs
tended to differentiate and the expression of USP21 gradually
decreased together with the pluripotency factors Oct4 and Nanog
(Figure 6b). To verify these ﬁndings, we tested an additional
differentiation induction model, which was induced by retinoic
acid. During the induced differentiation, the morphology of ESCs
signiﬁcantly changed (Figure 6c). Meanwhile, the protein levels of
USP21, Nanog and Oct4 were simultaneously reduced (Figure 6d).
These data suggest that higher level of USP21 may be related to
the pluripotency of ESCs.
To further examine the function of USP21 in mESCs, we
knocked down USP21 in mESC R1 cells. This led to decreased
Nanog expression (Figure 6e) and morphological changes in mESC
that correlates with decreased alkaline phosphatase staining
(Figure 6f). Consistently, after USP21 was knocked down, the
messenger RNA levels of pluripotency markers decreased, while
that of differential markers increased (Figure 6g). These results
indicate that USP21 has a role in maintaining ESCs in an
undifferentiated state.
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DISCUSSION
Stem cell transcription factors are highly regulated at the levels of
messenger RNA stability, translation and protein stability by
PTMs.22 Among the PTMs, ubiquitylation is a major regulator of
stem cell transcription factors, which can directly affect the
pluripotency of stem cells. Previous studies have found that
several core stem cell transcription factors undergo ubiquitylation
and proteasomal degradation. For instance, the stability and
transcriptional activity of Oct4 is regulated by Itch, a C2-WW-HECT
domain type of ubiquitin E3 ligase. Oct4 degradation impairs ESC
self-renewal and pluripotency.23 WWP2, another C2-WW-HECT
type of E3 ligase, can interact with both Oct4 and Sox2, resulting
in Oct4 and Sox2 downregulation and ESC differentiation.24,25 In
addition to the HECT-type E3 ligases, the Cullin–RING type of E3s
also have a critical role in regulation of stem cell transcription
factors. In this regard, E3 ligases SCFβ-TrCP1 and SCFβ-TrCP2 have
been shown to degrade Klf4,26,27 whereas SCFSkp2 and SCFFbw7 are
responsible for rapid c-Myc degradation.28–30 Nanog can maintain
the stemness of ESCs and reprogram somatic cells; however, the
PTMs of Nanog are still poorly understood. It has been reported
that Nanog is phosphorylated at multiple sites by protein kinase C,
focal adhesion kinase, ERKs and CDK1.17,31–34 Recently, the
ubiquitin ligase for Nanog has been identiﬁed, showing that the
F-box protein FBXW8 can reduce Nanog protein stability.17 ERK1,
but not ERK2, phosphorylates Nanog on Serines 52, 71 and 78, and
this phosphorylation induces the binding of FBXW8 with Nanog to
reduce Nanog protein stability. A previous study showed that
the PEST (enriched in Pro, Glu, Ser and Thr residues) motif in the
N-terminal part of Nanog (amino acids 47–72) is involved in the
rapid proteolysis and ubiquitylation of Nanog.35 Two phosphor-
ylation sites of Nanog by ERK1 are located within the PEST motif
(that is, Ser 52 and Ser 71). However, whether FBXW8 promotes
the ubiquitylation of Nanog through forming a Cullin–RING
complex (that is, FBXW8 acts as the substrate recognition subunit
of the E3 complex, similar to the pattern of SCFFbw7 and SCFβ-TrCP)
or not remains undeﬁned, which is worthy of further
investigations.
All the major PTMs, including the ubiquitylation process, can be
reversed. Ubiquitylation and deubiquitylation work properly in
a balanced manner to maintain stemness and permit
differentiation.20 Although several ubiquitin ligases of core stem
cell transcription factors have been shown, reports on the
functions of DUBs are limited. Recent evidence has revealed that
c-Myc can be deubiquitylated and regulated by USP28, USP36 and
USP37.36–38 Oct4 protein expression is decreased by depletion of
Psmd14, a deubiquitylating enzyme that resides in the 19S ‘lid’ of
the proteasome. In addition, Psmd14 expression is essential for
generating induced pluripotent stem cells.18 However, the
mechanism of Sox2, Oct4 and Nanog protein regulation by DUBs
is not well understood. In this study, we identiﬁed USP21 as a
candidate DUB for Nanog, but not Sox2 nor Oct4, and showed that
USP21 sustains the stemness of mESCs by stabilization of Nanog. It
is notable that USP21 expression is decreased during the ESC
differentiation, in contrast to the E3 ligase FBXW8, which remains
unchanged during this process. So far as we know, this is the ﬁrst
time a speciﬁc DUB for Nanog has been identiﬁed.
Our current ﬁndings, together with previous reports, suggest a
model in ESCs in which DUBs, such as USP21, are highly expressed
and help maintain high levels of Nanog, supporting ESC stemness
and pluripotency (Figure 7). During development, USP21 expres-
sion declines (although the molecular mechanism remains unclear
and needs further investigation), whereas activated ERK1 phos-
phorylates Nanog and promotes the E3 ligase FBXW8-mediated
ubiquitylation of Nanog. The latter event leads to the degradation
of Nanog and induction of differentiation (Figure 7). Therefore,
USP21, FBXW8 and ERK1 cooperate with each other to precisely
regulate the ‘Yin-Yang’ balance of the stability and activity of
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Nanog under the undifferentiated and differentiated states of
ESCs. These ﬁndings highlight the role of the network of protein
ubiquitylation and phosphorylation in stem cell control.
Among the whole family of DUBs, consisting of ~ 100 enzymes,
USPs are the largest subfamily, which contain450 members and
include conserved domains and catalytic sites.19,39,40 In this study,
we screened the USP and OTU subfamilies and identiﬁed USP21 as
a DUB for Nanog. However, we cannot rule out the possibility that
additional DUBs belonging to the other subfamilies such as
ubiquitin C-terminal hydrolyase, Jad/Pad/MPN domain-containing
metallo enzyme and monocyte chemotactic protein-induced
protein might also be responsible for Nanog deubiquitylation.
USP21 has been shown to deubiquitylate and stabilize H2A,
RIPK1, GATA3, RIG-1, IL-33 and Tip5.41–46 Interestingly, USP21 does
not only remove ubiquitin from ubiquitylated proteins but also
degrades conjugates of the ubiquitin-like protein ISG1547 and
according to some reports NEDD8.48 In addition, USP21 has an
important part in regulating microtubule- and centrosome-
associated processes.49 Our study identiﬁes the stem cell
transcription factor Nanog as a novel substrate of USP21. USP21
binds to the Nanog C-domain, a region that has been demon-
strated to have a critical role in transactivation potential.50 The
Nanog regulator H2A.Z also binds to the C-domain of Nanog and
promotes Nanog stability.51 Whether H2A.Z cooperates with
USP21 to regulate Nanog stability is worthy of further
investigation.
Ubiquitin can be conjugated to substrate proteins either as a
monoubiquitin or as polyubiquitin chains that varies in length and
linkage type. Depending on the lysine residue or the N terminus
methionine residue involved in the formation of the polyubiquitin
chain, there are a total of eight kinds of ubiquitin linkages that
have distinct physiological roles, that is, K6-, K11-, K27-, K29-, K33-,
K48-, K63- and M1-linkage (this type is also known as linear
ubiquitylation).39 K11-, K29- and K48-linked polyubiquitin chains
target proteins for proteasome degradation, whereas K63-,
M1-linked polyubiquitin chains and multiple monoubiquitin
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conjugation are preferentially involved in the nondegradative
signaling transduction or degradation through the lysosomal
pathway.52 USP21 can remove the K48- and K63-type of ubiquitin
chain depending on the cellular context and the substrate. For
instance, USP21 acts as a negative regulator of RIG-I and RIPK1 by
removing the K63-linkage of the ubiquitin chain, whereas it
deubiquitylates and stabilizes GATA3 by removing the K48-linkage
of the ubiquitin chain. Here we found that USP21 prefers to
remove K48 linkages of Nanog ubiquitylation and inhibits
proteasomal degradation, which is similar to the case of GATA3,
another nuclear transcription factor. Furthermore, human Nanog
protein contains a total of 18 lysines, most of which are located
within the N domain and the central Homeobox domain. Which
lysines are ubiquitylated in vivo and what is the effect of
ubiquitylation on Nanog activity should be explored in future
studies.
Nanog is capable of governing the pluripotency of ESCs and
early embryonic development.53,54 This study shows that USP21
appears to be necessary for the regulation of Nanog. Thus, we
propose USP21 may have a role during embryonic development.
Depletion of USP21 in mice may lead to abnormalities in
development or tissue homeostasis. Recently, two independent
studies showed that the USP21 knockout mice were viable and
fertile, spontaneously developed splenomegaly and were
more resistant to vesicular stomatitis virus infection with
elevated production of interferons. However, unexpectedly, the
knockout mice were not found to have abnormalities in cell
morphology, lymphocyte differentiation or hematopoietic stem
cell maintenance.44,55 To account for this puzzle, we must consider
why these phenomena did not occur. First, USP21 may not be the
sole ubiquitin-speciﬁc protease that catalyzes Nanog deubiquity-
lation. There might be additional DUBs besides USP21 that work
together to regulate Nanog during early embryonic development
in mice. Second, USP21 recognizes multiple substrates, either
positively or negatively regulating its stability, activity and/or
subcellular localization. Therefore, it is not surprising that certain
effects might be neutralized or counteracted.
In summary, this study identiﬁed USP21 as the speciﬁc DUB
interacting with Nanog, stabilizing Nanog by deubiquitylating
Nanog, and maintaining the pluripotency and self-renewal of
mESC. Depletion of USP21 caused mESC differentiation. These
ﬁndings provide novel insight into the role of USP21 in stem cell
fate decision. Future studies are required to determine the
physiological functions of USP21–Nanog axis in vivo.
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